257 related articles for article (PubMed ID: 1909152)
1. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators.
Fox KM; Dargie HJ; Deanfield J; Maseri A
Br Heart J; 1991 Aug; 66(2):151-5. PubMed ID: 1909152
[TBL] [Abstract][Full Text] [Related]
2. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.
Holdright DR; Katz RJ; Wright CA; Sparrow JL; Sullivan AK; Cunningham AD; Fox KM
Br Heart J; 1993 Mar; 69(3):223-7. PubMed ID: 8096389
[TBL] [Abstract][Full Text] [Related]
3. Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group.
Parker JO; Amies MH; Hawkinson RW; Heilman JM; Hougham AJ; Vollmer MC; Wilson RR
Circulation; 1995 Mar; 91(5):1368-74. PubMed ID: 7867175
[TBL] [Abstract][Full Text] [Related]
4. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
[TBL] [Abstract][Full Text] [Related]
5. Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin.
Nabel EG; Barry J; Rocco MB; Mead K; Selwyn AP
Am J Cardiol; 1989 Mar; 63(11):663-9. PubMed ID: 2493732
[TBL] [Abstract][Full Text] [Related]
6. Intermittent transdermal nitroglycerin therapy. Decreased anginal threshold during the nitrate-free interval.
Parker JD; Parker AB; Farrell B; Parker JO
Circulation; 1995 Feb; 91(4):973-8. PubMed ID: 7850984
[TBL] [Abstract][Full Text] [Related]
7. Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period.
Freedman SB; Daxini BV; Noyce D; Kelly DT
J Am Coll Cardiol; 1995 Feb; 25(2):349-55. PubMed ID: 7829787
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina.
Akhras F; Hellestrand K; Whalley D; Jackson G
Int J Cardiol; 1994 Mar; 43(3):251-6. PubMed ID: 8181883
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris.
James MA; Walker PR; Papouchado M; Wilkinson PR
Br Heart J; 1985 Jun; 53(6):631-5. PubMed ID: 3924081
[TBL] [Abstract][Full Text] [Related]
10. Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
Whalley DW; Hellestrand KJ
Aust N Z J Med; 1990 Oct; 20(5):677-81. PubMed ID: 2126727
[TBL] [Abstract][Full Text] [Related]
11. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate.
James MA; Papouchado M; Jones JV
Br Heart J; 1992 May; 67(5):421-2. PubMed ID: 1285761
[No Abstract] [Full Text] [Related]
12. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris.
de Milliano PA; Koster RW; Bär FW; Janssen J; de Cock C; Schelling A; van de Bos A
Am J Cardiol; 1991 Oct; 68(9):857-62. PubMed ID: 1927943
[TBL] [Abstract][Full Text] [Related]
13. Comparison of transdermal nitrate and isosorbide dinitrate in chronic stable angina.
Nicholls DP; Moles K; Gleadhill DN; Booth K; Rowan J; Morton P
Br J Clin Pharmacol; 1986 Jul; 22(1):15-20. PubMed ID: 3091055
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of nitrate effect during an intermittent treatment regimen and the time course of nitrate tolerance.
James MA; Papouchado M; Jones JV
Eur Heart J; 1991 Dec; 12(12):1266-72. PubMed ID: 1778190
[TBL] [Abstract][Full Text] [Related]
15. Transdermal nitroglycerin reduces the frequency of anginal attacks but fails to prevent silent ischemia.
Rossetti E; Luca C; Bonetti F; Chierchia SL
J Am Coll Cardiol; 1993 Feb; 21(2):337-42. PubMed ID: 8425995
[TBL] [Abstract][Full Text] [Related]
16. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina.
Gumbrielle T; Freedman SB; Fogarty L; Ogasawara S; Sobb P; Kelly DT
Eur Heart J; 1992 May; 13(5):671-8. PubMed ID: 1618212
[TBL] [Abstract][Full Text] [Related]
18. An acute double-blind placebo-controlled study of transdermal glyceryl trinitrate with 12 months' follow-up in patients with stable angina pectoris.
Heepe W
J Int Med Res; 1987; 15(4):198-204. PubMed ID: 3115846
[TBL] [Abstract][Full Text] [Related]
19. Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application.
Luke R; Sharpe N; Coxon R
J Am Coll Cardiol; 1987 Sep; 10(3):642-6. PubMed ID: 3114351
[TBL] [Abstract][Full Text] [Related]
20. Determination of the optimal dose of glyceryl trinitrate in the treatment of stable angina.
Mannering D; Kemp AL; Bennett ED
Eur Heart J; 1987 Jul; 8(7):744-7. PubMed ID: 3115779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
